title: Letter to the Editor: Re: Neurobehavioral Deficits, Diseases, and Associated Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union.
authors.affiliation: Beth Israel Deaconess Medical Center (R.J.M.), Joslin Diabetes Center (R.J.M.), and Harvard Medical School (R.J.M.), Boston, MA 02215; and American Enterprise Institute (S.A.V.), Washington, DC 20036.
authors.forename: Roeland J
authors.initials: RJ
authors.lastname: Middelbeek
authors.affiliation: Beth Israel Deaconess Medical Center (R.J.M.), Joslin Diabetes Center (R.J.M.), and Harvard Medical School (R.J.M.), Boston, MA 02215; and American Enterprise Institute (S.A.V.), Washington, DC 20036.
authors.forename: Stan A
authors.initials: SA
authors.lastname: Veuger
mesh_terms: D017281:Cost of Illness; D052244:Endocrine Disruptors / Q000633:toxicity*; D004700:Endocrine System Diseases / Q000191:economics*; D004781:Environmental Exposure / Q000191:economics*; D005062:European Union / Q000191:economics*; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000191:economics*
chemical_list: D052244:Endocrine Disruptors